by
Lauren Dubinsky, Senior Reporter | July 28, 2014
Gareen believes that all hospitals should use a standard consent form to inform the patients of the chances of a false positive result. "I think that this study should alert hospitals to the fact that they do need to make sure patients understand the screening process," she said.
The United States Preventive Services Task Force (USPSTF) recommended annual CT lung cancer screening for patients at high risk last December. Starting Jan. 1, 2015, private insurers will be required to cover it under the Affordable Care Act but Medicare is not required to abide by USPSTF recommendations.
Ad Statistics
Times Displayed: 45539
Times Visited: 1299 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
The Centers for Medicare and Medicaid will make its final decision regarding coverage in February. Gareen thinks that the results of her study may influence CMS's decision because two issues cited in the Medicare Payment Advisory Commission document were anxiety and quality of life.
She also participated in a cost effectiveness analysis of CT lung cancer screening which was conducted by Dr. William Black of the Geisel School of Medicine at Dartmouth College. She hopes it will be coming out soon and she thinks that it may also influence CMS's decision.
Back to HCB News
